Меню
Идёт набор NCT07187934

EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING

Без фазы С лечением Pregnancy

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: AI algorithm.
Кому может быть актуально
Состояния в реестре: Pregnancy. Базовые параметры: 18 лет — 42 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Бельгия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

PROSPECTIVE EVALUATION OF THE IDASCORE ALGORITHM FOR EMBRYO RANKING

Обзор

This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.

Подробное описание

The study population consists of IVF/ICSI patients scheduled for a freeze-all policy on day 5. Inclusion takes place on the day prior to oocyte retrieval, based on predefined inclusion criteria. Embryo culture is performed in an EmbryoScope+ time-lapse incubator. On day 5 of embryo development, the embryologist evaluates the embryos using the Gardner criteria, assessing expansion stage, inner cell mass (ICM), and trophectoderm (TE). All embryos meeting our in-house cryopreservation criteria are vitrified. Embryos not yet meeting the criteria remain in culture and are re-evaluated on day 6. Once at least two blastocysts meet the cryopreservation criteria on day 5 and/or day 6, the patient is randomized in the control or study arm.

In the control group, the embryologist manually ranks all freezable embryos according to the assigned Gardner scores, applying a standard prioritization scheme: day of cryopreservation \> expansion stage \> TE score \> ICM score.

If multiple embryos share the same Gardner score, the embryologist looks at the full morphokinetics to establish a final ranking. The order of warming for subsequent frozen embryo transfer (FET) cycles follows this ranking: the embryo ranked 1 is transferred first. If no clinical pregnancy results, the embryo ranked 2 is transferred in the next FET cycle, and so on.

In the study group, the iDA score is retrieved for each freezable embryo. Embryos are ranked solely based on their iDA score, with the highest score assigned rank 1, and so on. The order of warming for subsequent FET cycles is determined exclusively by this ranking. As in the embryologist group, the embryo ranked 1 is transferred first, followed by rank 2 in case of no clinical pregnancy, and so on.

+/- 10 days after embryo transfer, an hCG blood test is performed. In case of a positive result, the pregnancy is monitored until the 7-week ultrasound, at which the presence of fetal heartbeat confirms a clinical pregnancy. Patients are followed for clinical pregnancy outcomes of FETs performed up to one year after oocyte retrieval, or until the pregnancy outcome of the last available embryo is known.

In both the study and control arm, all procedures follow the standard of care. The only difference between the groups is the method of embryo ranking-and therefore the order in which embryos will be transferred.

Вмешательства

  • Устройство AI algorithm
    iDAScore® is a deep learning-based tool that provides fully automated analysis of embryo time-lapse images. It automatically generates a score (1-9.9) for each embryo in the patient's embryo cohort, which correlates to the likelihood of achieving a fetal heartbeat (clinical pregnancy).

Первичные конечные точки

  • Transfer to pregnancy [Срок оценки: The patient is followed up for clinical pregnancy outcomes (7-week echo) up until 1 year after the oocyte retrieval date, or until the result of the last available embryo is known.]
Вторичные конечные точки (4)
  • iDA-embryologist consensus [Срок оценки: Embryo ranking is done on day 5 and/or 6 of embryo development and can be immediately compared during ranking.]
  • Embryo prioritization time [Срок оценки: Measures the time elapsing between the start and end of embryo prioritisation (range of minutes). Is recorded on day 5 and day 6 of embryo development right after embryo evaluation.]
  • Cumulative clinical pregnancy rate [Срок оценки: Up until 1 year after oocyte retrieval]
  • Clinical pregnancy rate after the first embryo transfer [Срок оценки: Clinical pregnancy is determined at the 7 week echo by detection of a fetal heart beat.]

Критерии участия

Критерии включения

  • patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
  • all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
  • Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
  • 18 ≤ Age ≤ 42 years
  • 18 ≤ BMI ≤ 35 kg/m²
  • Maximum third IVF/ICSI cycle
  • Participants can be included only once in the trial

Критерии исключения

  • Embassy patients
  • Use of frozen oocytes
  • In vitro maturation (IVM) cycles
  • Pre-implantation genetic Testing (PGT) cycles
  • Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
  • Endometriosis stage 3/4

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Диагностика

Центры проведения

Бельгия · 1 центр
  • Brussels IVF, UZ Brussel — Brussels

Идентификаторы

NCT: NCT07187934 · PRIDE_2025

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗